Terms: = Prostate cancer AND ZBTB16, Q05516, 7704, ENSG00000109906, ZNF145, PLZF AND Treatment
9 results:
1. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.
Dahal S; Chaudhary P; Kim JA
Cell Oncol (Dordr); 2023 Aug; 46(4):1113-1126. PubMed ID: 36995683
[TBL] [Abstract] [Full Text] [Related]
2. ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in prostate cancer.
Han D; Chen S; Han W; Gao S; Owiredu JN; Li M; Balk SP; He HH; Cai C
Cancer Res; 2019 Oct; 79(20):5260-5271. PubMed ID: 31444154
[TBL] [Abstract] [Full Text] [Related]
3. Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.Cell. 21 May 2015;161(5):1215-1228.
Freedland SJ; Aronson WJ
Urol Oncol; 2017 Aug; 35(8):535. PubMed ID: 28623072
[TBL] [Abstract] [Full Text] [Related]
4. Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for prostate cancer.
Chiu PK; Alberts AR; Venderbos LDF; Bangma CH; Roobol MJ
BJU Int; 2017 Sep; 120(3):394-400. PubMed ID: 28498624
[TBL] [Abstract] [Full Text] [Related]
5. Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant prostate cancer Growth.
Kach J; Long TM; Selman P; Tonsing-Carter EY; Bacalao MA; Lastra RR; de Wet L; Comiskey S; Gillard M; VanOpstall C; West DC; Chan WC; Griend DV; Conzen SD; Szmulewitz RZ
Mol Cancer Ther; 2017 Aug; 16(8):1680-1692. PubMed ID: 28428441
[TBL] [Abstract] [Full Text] [Related]
6. Integrative clinical genomics of advanced prostate cancer.
Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
[TBL] [Abstract] [Full Text] [Related]
7. plzf mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.
Cao J; Zhu S; Zhou W; Li J; Liu C; Xuan H; Yan J; Zheng L; Zhou L; Yu J; Chen G; Huang Y; Yu Z; Feng L
PLoS One; 2013; 8(12):e77922. PubMed ID: 24339862
[TBL] [Abstract] [Full Text] [Related]
8. Fast neutrons in prostatic adenocarcinomas: worldwide clinical experience.
Lindsley KL; Cho P; Stelzer KJ; Koh WJ; Austin-Seymour M; Russell KJ; Laramore GE; Griffin TW
Recent Results Cancer Res; 1998; 150():125-36. PubMed ID: 9670287
[TBL] [Abstract] [Full Text] [Related]
9. Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: updated results of the RTOG 7704 randomized clinical trial.
Russell KJ; Laramore GE; Krall JM; Thomas FJ; Maor MH; Hendrickson FR; Krieger JN; Griffin TW
Prostate; 1987; 11(2):183-93. PubMed ID: 3118342
[TBL] [Abstract] [Full Text] [Related]
